Business Context and Reporting Period
Company: Oragenics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: October 31, 2003
Reporting Period: Specific event date of October 31, 2003.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a specific corporate governance event rather than periodic financial performance.
Material Changes
There are no material changes to financial results or operations reported in this document. The sole material event disclosed is the granting of stock options to specific individuals.
Guidance, Outlook, and Management Commentary
Regulation FD Disclosure: The company announced the granting of stock options to Paul Hassie and Brian Anderson.
Management Commentary: No forward-looking guidance, risk factors, or unusual items were disclosed in this filing.
Investor Verification Checklist
- Verify the terms and vesting schedule of the stock options granted to Paul Hassie and Brian Anderson.
- Confirm the impact of these grants on the company's total outstanding share count and potential dilution.
- Review the referenced Press Release (Exhibit 99.1) for additional context not included in the 8-K text.